Feature
May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the CoreValve system via alternative access approaches. The data were unveiled during a late-breaking clinical session at the 94th American Association for Thoracic Surgery (AATS) annual meeting.
May 02, 2014
Technology
May 2, 2014 — Terso Solutions Inc., a provider of automated inventory management solutions for healthcare and life science, announced that Endologix Inc. has partnered with them for a fully automated, on-site consignment inventory program. Endologix chose Terso for their proven track record with both RFID (radio frequency identification device) solutions for medical device inventory management and cold chain security.
May 02, 2014News
May 1, 2014 — Government regulations and JCAHO (Joint Commission) certification are driving providers to make purchasing plans for dose monitoring solutions, and in discussions about these plans, two vendors are capturing the majority of providers' mindshare. This is according to the latest KLAS report, Radiology Dose Monitoring Solutions 2014: Provider Strategies in an Evolving Market.
May 01, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Technology
May 1, 2014 — Nuance Communications announced the immediate availability of the Nuance PowerShare network, the industry’s largest cloud-based network for securely connecting healthcare professionals to share essential medical images and reports as simply as people exchange information using social networks. The PowerShare network promotes fully informed and connected physicians and patients who instantly view, share and collaborate while addressing patients’ healthcare needs.
May 01, 2014
News
Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced drug-eluting stent (DES) technology system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval.
May 01, 2014Technology
Volcano Corp. announced the commencement of its limited market release of its U.S. Food and Drug Administration (FDA) cleared and CE marked technology SyncVision, with cases being performed in the United States and Europe.
May 01, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Gavin Finn, President and CEO of Kaon Interactive
It is impossible to escape the reality that as the use of mobile electronic devices increases amongst consumers, a proportionate increase in the use of such devices in the medical sales and marketing arena will follow. This is already a significant trend that has spread from pharmaceutical sales to device providers and, indeed, through all aspects of the interaction between physicians and their providers of tools and solutions.
April 30, 2014
Feature | Jen Ireland and Val Kapitula, Ascendian Healthcare Consulting
A successfully implemented CVIS solution allows your organization to modernize and optimize the cardiovascular service line. Breaking down the advantages into terms and next steps you can discuss with your executive suite is essential and will allow you to analyze potential vendor’s offerings and organizational gaps as you move from your legacy environment to the "new vision." Consider the following benefits and features as you develop a comprehensive road map for your future cardiovascular operations and services:
April 30, 2014
News
Imris Inc. announced that a University of South Florida neurosurgical team at Tampa General Hospital (TGH) completed initial cases using its recently installed Visius intraoperative MRI (magnetic resonance imaging) — providing the most advanced surgery and operating suite in the Tampa Bay area.
April 30, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
April 30, 2014 — Fovia Medical Inc. and Imperial College London, a science-based institution in biomedical research, announced a collaboration to bring High Definition Volume Rendering (HDVR) to minimally invasive robotic surgery.
April 30, 2014
News
National Institutes of Health (NIH) researchers have identified gene variants that cause a rare syndrome of sporadic fevers, skin rashes and recurring strokes, beginning early in childhood.
April 30, 2014
News
Scripps Health became the first health care provider in Southern California to implant the investigational Nanostim leadless pacemaker, the world's first wireless pacemaker totally implanted in the heart, as part of the Leadless II Clinical Trial.
April 30, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature
April 30, 2014 — Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a new ultrasound device that could help identify arterial plaque that is at high risk of breaking off and causing heart attack or stroke.
April 30, 2014
News
April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing hospitalizations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb negative. Celladon is a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies.
April 30, 2014News
April 29, 2014 — Armetheon Inc. announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a special protocol assessment (SPA) for the final pivotal trial of tecarfarin. Tecarfarin is positioned to be the only oral anticoagulant therapy for patients with prosthetic heart valves (PHV) specifically identified in the label.
April 29, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now